Literature DB >> 6235821

Brain monoaminergic control of male reproductive behavior. I. Serotonin and the post-ejaculatory refractory period.

T K McIntosh, R J Barfield.   

Abstract

The present experiment was performed to examine the role of serotonergic mechanisms in the control of copulation and the post-ejaculatory refractory period in the male rat. Disruption of central serotonergic systems in two separate groups of animals was achieved by: (1) selective electrolytic lesions of the midbrain raphe nuclei, or (2) localized intraventricular or intracerebral injection of a specific serotonergic neurotoxin, 5,7-dihydroxytryptamine (5,7-DHT). A third group of animals was tested for sexual behavior following intraperitoneal injection of p-chlorophenylalanine (PCPA), an inhibitor of serotonin synthesis. Both electrolytic and neurochemical lesions localized in the dorsal raphe nucleus produced a highly significant shortening of the ejaculatory latency, and the post-ejaculatory refractory period. Disruption of serotonergic mechanisms following intraventricular injection of 5,7-DHT or systemic administration of PCPA also caused a significant reduction in the length of the refractory period. These results support the hypothesis that central serotonergic systems are normally inhibitory to certain facets of male copulatory behavior and suggest the existence of a serotonergic control system which normally exerts an inhibitory influence over the resumption of mating following ejaculation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235821     DOI: 10.1016/0166-4328(84)90151-7

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  15 in total

1.  Neuromodulator role of luliberin in the regulation of sexual behavior in the male rat.

Authors:  V N Babichev; E I Adamskaya; T V El'tseva
Journal:  Neurosci Behav Physiol       Date:  1991 Jul-Aug

2.  A role for 5-hydroxytryptamine in descending inhibition of spinal sexual reflexes.

Authors:  L Marson; K E McKenna
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

3.  Sertraline in the treatment of premature ejaculation: a double-blind placebo controlled study.

Authors:  H Biri; K Isen; Z Sinik; M Onaran; B Küpeli; I Bozkirli
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 4.  The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.

Authors:  Sheryl A Kingsberg; Anita H Clayton; James G Pfaus
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

5.  Comparison of the effects of different isomers of bicuculline infused in the preoptic area on male rat sexual behavior.

Authors:  A Fernández-Guasti; K Larsson; C Beyer
Journal:  Experientia       Date:  1985-11-15

Review 6.  Specific involvement of central 5-HT1A receptors in the mediation of male rat ejaculatory behavior.

Authors:  S Ahlenius; K Larsson
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

7.  Serotonergic lesions of the periaqueductal gray, a primary source of serotonin to the nucleus paragigantocellularis, facilitate sexual behavior in male rats.

Authors:  Joseph J Normandin; Anne Z Murphy
Journal:  Pharmacol Biochem Behav       Date:  2011-02-03       Impact factor: 3.533

8.  Participation of 5-HT(1B) receptors in the inhibitory actions of serotonin on masculine sexual behaviour of mice: pharmacological analysis in 5-HT(1B) receptor knockout mice.

Authors:  Gabriela Rodríguez-Manzo; Carolina López-Rubalcava; Rene Hen; Alonso Fernández-Guasti
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

9.  Neurologic factors in female sexual function and dysfunction.

Authors:  Kazem M Azadzoi; Mike B Siroky
Journal:  Korean J Urol       Date:  2010-07-20

Review 10.  The hormonal control of ejaculation.

Authors:  Giovanni Corona; Emmanuele A Jannini; Linda Vignozzi; Giulia Rastrelli; Mario Maggi
Journal:  Nat Rev Urol       Date:  2012-08-07       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.